Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 9607054, 9 pages
http://dx.doi.org/10.1155/2016/9607054
Research Article

VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular Carcinoma

1Research Centre for Biochemistry and Molecular Biology, Medical School of São José do Rio Preto (FAMERP), São José do Rio Preto, SP, Brazil
2Hepatology Unit, HB University Medical Centre, FUNFARME/FAMERP, São José do Rio Preto, SP, Brazil
3Liver Transplantation Unit, HB University Medical Centre, FUNFARME/FAMERP, São José do Rio Preto, SP, Brazil

Received 18 February 2016; Revised 10 July 2016; Accepted 4 August 2016

Academic Editor: Aldo J. Montano-Loza

Copyright © 2016 Maria Eduarda Lopes Baitello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Gomes, D. N. Priolli, J. G. Tralhão, and M. F. Botelho, “Carcinoma hepatocelular: epidemiologia, biologia, diagnóstico e terapias,” Revista da Associação Médica Brasileira, vol. 59, no. 5, pp. 514–524, 2013. View at Publisher · View at Google Scholar
  2. World Health Organization, GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, 2014, http://globocan.iarc.fr.
  3. K. J. Lafaro, A. N. Demirjian, and T. M. Pawlik, “Epidemiology of hepatocellular carcinoma,” Surgical Oncology Clinics of North America, vol. 24, no. 1, pp. 1–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Asghar and T. Meyer, “Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?” Journal of Hepatology, vol. 56, no. 3, pp. 686–695, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Crissien and C. Frenette, “Current management of hepatocellular carcinoma,” Gastroenterology and Hepatology, vol. 10, no. 3, pp. 153–161, 2014. View at Google Scholar · View at Scopus
  7. A. Flores and J. A. Marrero, “Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics,” Clinical Medicine Insights: Oncology, vol. 8, pp. 71–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. W.-L. Shih, H.-C. Chang, Y.-F. Liaw et al., “Influences of tobacco and alcohol use on hepatocellular carcinoma survival,” International Journal of Cancer, vol. 131, no. 11, pp. 2612–2621, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. F. Felizardo and N. O. S. Câmara, “Hepatocellular carcinoma and food contamination: aflatoxins and ochratoxin A as great prompter,” World Journal of Gastroenterology, vol. 19, no. 24, pp. 3723–3725, 2013. View at Google Scholar
  10. A. Moeini, H. Cornellà, and A. Villanueva, “Emerging signaling pathways in hepatocellular carcinoma,” Liver Cancer, vol. 1, no. 2, pp. 83–93, 2012. View at Publisher · View at Google Scholar
  11. M. Fernández, D. Semela, J. Bruix, I. Colle, M. Pinzani, and J. Bosch, “Angiogenesis in liver disease,” Journal of Hepatology, vol. 50, no. 3, pp. 604–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Coulon, F. Heindryckx, A. Geerts, C. Van Steenkiste, I. Colle, and H. Van Vlierberghe, “Angiogenesis in chronic liver disease and its complications,” Liver International, vol. 31, no. 2, pp. 146–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Liang, F. Xu, X. Li, C. Ma, Y. Zhang, and W. Xu, “VEGF signal system: the application of antiangiogenesis,” Current Medicinal Chemistry, vol. 21, no. 7, pp. 894–910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Shibuya, “VEGF-VEGFR signals in health and disease,” Biomolecules and Therapeutics, vol. 22, no. 1, pp. 1–9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Jain, C. A. Vargo, R. Danesi et al., “The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors,” Molecular Cancer Therapeutics, vol. 8, no. 9, pp. 2496–2508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Wu, Z. Xin, W. Zhang et al., “Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity,” International Journal of Cancer, vol. 133, no. 5, pp. 1085–1093, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Zhai, M. N. Gong, W. Zhou et al., “Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS,” Thorax, vol. 62, no. 8, pp. 718–722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. I. Koukourakis, D. Papazoglou, A. Giatromanolaki, G. Bougioukas, E. Maltezos, and E. Siviridis, “VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer,” Lung Cancer, vol. 46, no. 3, pp. 293–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer-Pietsch, and E. Pilger, “A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels,” Journal of Vascular Research, vol. 37, no. 6, pp. 443–448, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Giacalone, G. Montalto, L. Giannitrapani et al., “Association between single nucleotide polymorphisms in the Cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma,” OMICS, vol. 15, no. 3, pp. 193–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Ministério da Saúde (BR), “Ordinance no. 2.712, of 2013 November 12. Redefine o regulamento técnico de procedimentos hemoterápicos,” Diário Oficial da União. Seção 1, 2013.
  22. L. A. Salazar, M. H. Hirata, S. A. Cavalli, M. O. Machado, and R. D. C. Hirata, “Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing,” Clinical Chemistry, vol. 44, no. 8, pp. 1748–1750, 1998. View at Google Scholar · View at Scopus
  23. G. Testino, S. Leone, and P. Borro, “Alcohol and hepatocellular carcinoma: a review and a point of view,” World Journal of Gastroenterology, vol. 20, no. 43, pp. 15943–15954, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Crawford, “Histologic findings in alcoholic liver disease,” Clinics in Liver Disease, vol. 16, no. 4, pp. 699–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Fullwood, “Alcohol-related liver disease,” Nursing Standard, vol. 28, no. 46, pp. 42–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Purohit, R. Rapaka, O. S. Kwon, and B. J. Song, “Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma,” Life Sciences, vol. 92, no. 1, pp. 3–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Mittal and H. B. El-Serag, “Epidemiology of HCC: consider the population,” Journal of Clinical Gastroenterology, vol. 47, pp. S2–S6, 2013. View at Publisher · View at Google Scholar
  28. World Health Organization, Hepatitis B: Fact Sheet, 2014, http://www.who.int/mediacentre/factsheets/fs204/en/.
  29. A. Minchenko, S. Salceda, T. Bauer, and J. Caro, “Hypoxia regulatory elements of the human vascular endothelial growth factor gene,” Cellular and Molecular Biology Research, vol. 40, no. 1, pp. 35–39, 1994. View at Google Scholar · View at Scopus
  30. M. Mohammadi, W. E. Ollier, and I. V. Hutchinson, “A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells,” Human Immunology, vol. 64, no. 10, article S125, 2003. View at Publisher · View at Google Scholar
  31. A. O. Kaseb, A. Hanbali, M. Cotant, M. M. Hassan, I. Wollner, and P. A. Philip, “Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature,” Cancer, vol. 115, no. 21, pp. 4895–4906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Song, L. Z. Wang, X. Li et al., “Polymorphisms of vascular endothelial growth factor on prognosis in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization treatment,” Genetics and Molecular Research, vol. 13, no. 4, pp. 8946–8953, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. Bradbury, R. Zhai, C. Ma et al., “Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis,” Clinical Cancer Research, vol. 15, no. 14, pp. 4680–4685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Vidaurreta, R. Sánchez-Muñoz, S. Veganzones et al., “Vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer,” Revista Española de Enfermedades Digestivas, vol. 102, no. 1, pp. 20–31, 2010. View at Google Scholar · View at Scopus
  35. G. Supic, N. Jovic, K. Zeljic, R. Kozomara, and Z. Magic, “Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients,” Oral Oncology, vol. 48, no. 11, pp. 1171–1177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. T.-T. Hong, R.-X. Zhang, X.-H. Wu, and D. Hua, “Polymorphism of vascular endothelial growth factor −1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies,” Molecular Biology Reports, vol. 39, no. 5, pp. 5283–5289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. T. P. Lau, A. C. Roslani, L. H. Lian et al., “Association between EGF and VEGF functional polymorphisms and sporadic colorectal cancer in the Malaysian population,” Genetics and Molecular Research, vol. 13, no. 3, pp. 5555–5561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Rinck-Junior, C. Oliveira, G. J. Lourenço et al., “Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 1, pp. 69–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Yang, X. Zhang, D. Song, and J. Wei, “Association between vascular endothelial growth factor gene polymorphism and bladder cancer risk,” Molecular and Clinical Oncology, vol. 2, no. 4, pp. 501–505, 2014. View at Google Scholar
  40. T. Mukozu, H. Nagai, D. Matsui, T. Kanekawa, and Y. Sumino, “Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma,” Anticancer Research, vol. 33, no. 3, pp. 1013–1021, 2013. View at Google Scholar · View at Scopus
  41. S.-Y. Kong, J.-W. Park, A. L. Jung et al., “Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients,” Hepatology, vol. 46, no. 2, pp. 446–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. E. G. Yegin, A. Siykhymbayev, F. Eren, N. Bekiroglu, and O. C. Ozdogan, “Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging,” Annals of Hepatology, vol. 12, no. 6, pp. 915–925, 2013. View at Google Scholar · View at Scopus
  43. P. Zhan, Q. Qian, and L.-K. Yu, “Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis,” Hepatobiliary Surgery and Nutrition, vol. 2, no. 4, pp. 209–215, 2013. View at Publisher · View at Google Scholar
  44. W. T. El-Sherif, N. A. Makhlouf, S. S. El-Gendi, H. I. Hassan, and O. M. Herdan, “Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma,” The Egyptian Journal of Immunology, vol. 19, no. 2, pp. 53–65, 2012. View at Google Scholar · View at Scopus
  45. M. E. El-Houseini, M. S. Mohammed, W. M. Elshemey, T. D. Hussein, O. S. Desouky, and A. A. Elsayed, “Enhanced detection of hepatocellular carcinoma,” Cancer Control, vol. 12, no. 4, pp. 248–253, 2005. View at Google Scholar · View at Scopus